Neolys Diagnostics is a biological analysis society, based in Lyon (France). It proposes a real decision-making tool to the radiation oncologists, allowing them to adapt treatment to the individual radiosensitivity of the patient, in order to reduce side effects, while optimizing the treatment efficiency.

Neolys Diagnostics is a biological analysis society, based in Lyon (France). It proposes an efficient decision-making tool to radiation oncologists, allowing them to adapt treatment as per radiosensitivity of individual patient. This helps in reducing side effects while optimizing the treatment efficiency.    

This disruptive innovation relies on individual radiosensitivity researches carried-out by the Radiobiology Group of the CRCL  (UMR1052). 

 

Neolys Diagnostics founders are glad to introduce to you the elements of this ambitious project. 

Founders

Gilles Devillers, Nicolas Foray, Julien Gillet-Daubin

Last news

27th Congress of the French Society of Radiation Oncology (SFRO)

27th Congress of the French Society of Radiation Oncology (SFRO) October 2016 Last October was held in Paris the 27t...

Fundraising & Marketing

Fundraising & Marketing June 2016 After having mobilized more than €1.2 million "non-dilutive" (without capit...

Off to Boston !

Off to Boston ! February 2016  After being selected among the 20 Big Booster finalists, Neolys are taking off to the ...

All news

Our Technology

Our technology is the result of over ten years of research by the Radiobiology Group. Their work on individual sensitivity have allowed to set up predictive tests. This technology offers a promissing solution, optimizing the efficiency of radiotherapy treatments and preventing toxicity at the same time.

Read more +